Simulation for Designing Clinical Trials discusses:
- selecting clinical trial designs according to their probability for success
- techniques to define distributions of virtual subjects’ characteristics
- methods to determine the sensitivity of the trial design
- the population relationship between dosing schedules and patient response
Contents
- Introduction to Simulation for Design of Clinical Trials
Models for Simulation
- Input-Output Models
- Defining Covariate Distribution Models for Clinical Trial Simulation
- Protocol Deviations and Execution Models
- Determination of Model Appropriateness
Computation in Simulation
- Computational Considerations in Clinical Trial Simulations
Analyses of the Simulations
- Analysis of Simulated Clinical Trials
- Sensitivity Analysis of Pharmacokinetic and Pharmacodynamic Models in Clinical Trial Simulation and Design
- Choice of Best Design
Perspectives on Clinical Trial Simulation
- Clinical Trial Simulation (CTS): A Regulatory Clinical Pharmacology Perspective
- Academic Perspective: Modeling and Simulation as a Teaching Tool
- Modeling and Simulation of Clinical Trials: An Industry Perspective
- History-Informed Perspectives on the Modeling and Simulation of Therapeutic Drug Actions
Applications
- Evaluation of Random Sparse Sampling Designs for a Population Pharmacokinetic Study: Assessment of Power and Bias Using Simulation
- Use of Modeling and Simulation to Optimize Dose-Finding Strategies
- Model-Based Integration for Clinical Trial Simulation and Design: A Phase II Case Study for Naratriptan
- Prediction of Hemodynamic Responses in Hypertensive and Elderly Subjects from Healthy Volunteer Data: The Example of Intravenous Nicardipine
- Assessment of QTc Interval Prolongation in a Phase I Study Using Monte Carlo Simulation
- Optimizing a Bayesian Dose-Adjustment Scheme for a Pediatric Trial: A Simulation Study
Index